iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 3,805.00
+45.00 (1.20%)
Oct 10, 2025, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 120.29 billion as of October 10, 2025. Its market cap has decreased by -37.28% in one year.
Market Cap
120.29B
Enterprise Value
79.96B
Revenue
5.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,805.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 120.29B, an increase of 26.23%. That is a compound annual growth rate of 1.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 120.29B | -34.47% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | 915.06B | 97.15% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |